Suven Pharmaceuticals standalone net profit declines 31.49% in the September 2022 quarter

Sales decline 7.51% to Rs 278.40 crore

Net profit of Suven Pharmaceuticals declined 31.49% to Rs 78.92 crore in the quarter ended September 2022 as against Rs 115.20 crore during the previous quarter ended September 2021. Sales declined 7.51% to Rs 278.40 crore in the quarter ended September 2022 as against Rs 300.99 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales278.40300.99 -8 OPM %38.3040.46 -PBDT116.74158.94 -27 PBT105.98149.76 -29 NP78.92115.20 -31

Powered by Capital Market - Live News